Skip to main content
Epigenomics AG logo

Epigenomics AG — Investor Relations & Filings

Ticker · ECX ISIN · DE000A37FT41 LEI · 549300X1C4U862NDLN97 F Financial and insurance activities
Open in API
Filings indexed 90 across all filing types
Latest filing 2025-05-02 Annual Report
Country DE Germany
Listing F ECX

About Epigenomics AG

https://www.epigenomics.com/

Epigenomics AG operates as a holding company dedicated to managing its assets and investments. The company's primary investment focus is on the field of molecular diagnostics, particularly in companies developing minimally invasive, blood-based tests for the early detection of cancer. This strategy leverages the company's historical expertise in the development of in vitro diagnostic products based on DNA methylation biomarkers.

Recent filings

Filing Released Lang Actions
Jahresabschluss zum Geschäftsjahr vom 01.01.2024 bis zum 31.12.2024
Annual Report Classification · 100% confidence The document is titled 'Jahresfinanzbericht' (Annual Financial Report) for Epigenomics AG for the fiscal year 2024. It contains a management report (Lagebericht), balance sheet (Bilanz), profit and loss statement (Gewinn- und Verlustrechnung), and other financial disclosures required for a full annual report. It is not an announcement of a report, but the report itself, and it contains substantive financial data. FY 2024
2025-05-02 German
Report Publication Announcement 2025
Report Publication Announcement Classification · 100% confidence The document is titled "Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG". It explicitly states that the Annual financial report for the business year 2024 will be disclosed on April 29, 2025, and provides a link to where it will be available. Since the document itself is an announcement about the future release of a report (the Annual financial report), and not the report itself, it fits the definition of a Report Publication Announcement (RPA). The document length (1831 chars) is very short, supporting the 'MENU VS MEAL' rule application.
2025-04-28 English
Hinweis auf Jahresfinanzbericht vom 01.01.2024 bis zum 31.12.2024
Report Publication Announcement Classification · 98% confidence The document is very short (845 characters) and explicitly functions as a notice. The key phrases are 'Hinweis auf Jahresfinanzbericht' (Notice of Annual Financial Report) and 'Der Finanzbericht steht zur Verfügung' (The financial report is available) followed by a link and the publication date (29.04.2025). This structure indicates an announcement about the availability of a report, not the report itself. Since it announces the availability of a financial report (Jahresfinanzbericht), it fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports.
2025-04-28 German
Epigenomics AG: Jahresergebnis zum 31. Dezember 2024 und Prognoseabweichung
Earnings Release Classification · 100% confidence The document is titled "Epigenomics AG: Jahresergebnis zum 31. Dezember 2024 und Prognoseabweichung" (Annual Result as of December 31, 2024, and Forecast Deviation). It explicitly discusses the preliminary annual results for the fiscal year 2024, including the net loss and available liquidity as of December 31, 2024. Although it mentions that the final annual financial statements are being finalized, the core content is the announcement of the full-year financial performance and the deviation from the initial forecast. This strongly indicates an Earnings Release (ER) or, given the comprehensive nature of discussing the full year and adjustments, it leans towards the initial announcement of the annual results, which is often categorized as an Earnings Release (ER) when it precedes the formal 10-K filing, or potentially an Interim/Quarterly Report (IR) if it were for a shorter period, but since it covers the full year (01. Januar bis 31. Dezember 2024), ER is the most appropriate fit for the initial release of annual figures. It is not the full 10-K, nor is it just a management discussion (MDA) or a simple dividend notice. Since it is an announcement of the annual result, ER is the best fit among the options provided for an initial results disclosure. FY 2024
2025-04-23 German
Epigenomics AG: Vorlaufiges Jahresergebnis zum 31. Dezember 2024
Earnings Release Classification · 100% confidence The document is titled "Epigenomics AG: Vorläufiges Jahresergebnis zum 31. Dezember 2024" (Preliminary Annual Result as of December 31, 2024). It provides key preliminary financial figures for the full fiscal year 2024, including net loss, available cash, and balance sheet details (negative equity). It explicitly states that these figures are preliminary and subject to final audit and approval by the Supervisory Board. This content aligns perfectly with an Earnings Release (ER), which is the initial announcement of periodical financial results, even though it covers the full year, as it is a preliminary summary released before the final audited 10-K. It is not the comprehensive 10-K itself, nor is it a general announcement about a report (RPA). FY 2024
2025-01-22 German
Epigenomics AG: Vorlaufiges Jahresergebnis zum 31. Dezember 2024
Earnings Release Classification · 100% confidence The document is titled "Epigenomics AG: Vorläufiges Jahresergebnis zum 31. Dezember 2024" (Preliminary Annual Result as of December 31, 2024). It provides key preliminary financial figures for the full fiscal year 2024, including net loss, available cash, and balance sheet details (negative equity). It explicitly states that these figures are preliminary and subject to final audit and approval by the Supervisory Board. This content aligns perfectly with an Earnings Release (ER), which is the initial announcement of periodical financial results, even though it covers the full year, as it is a preliminary summary released before the final audited 10-K. It is not the comprehensive 10-K itself, nor is it a general announcement about a report (RPA). FY 2024
2025-01-21 German

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.